Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes

Pulmonary Pharmacology and Therapeutics

Volumn 12, Issue 1, 1999, Pages 55-60

  Eleno, N ^a   Gajate, E ^a   Macias, J ^a,b   Garay, R P ^a,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c INSERM   (France)

Author keywords

Asthma; Disodium cromoglycate; Histamine; Mastocytes; Reproterol

Indexed keywords

BRONCHODILATING AGENT; COMPOUND 48-80; CROMOGLYCATE DISODIUM; FORSKOLIN; HISTAMINE; HISTAMINE RELEASE INHIBITOR; REPROTEROL; SALBUTAMOL; THEOPHYLLINE;

ANIMAL CELL; ARTICLE; ASTHMA; BRONCHUS MUSCLE; CONTROLLED STUDY; DRUG POTENTIATION; HISTAMINE RELEASE; INFLAMMATORY CELL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033080954     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0171     Document Type: Article

References (25)

1. Barnes P J, O'Connor B J. Use of a fixed combination β2- Agonist and steroid dry powder inhaler in asthma. Am J Respir Crit Care Med 1995; 151: 1053-1057.
2. Reproterol - A ten year update. Drugs of Today 1986; 22: 385-413.
3. Petro W, Ernst U, Konietzko N. Reactivity and sensitivity of the airways tract during therapy with DSCG and β2 adrenergic agents. Atemw-Lungenkrkh Jahrgang 1984; 10: S367-S369.
4. Murphy S, Kelly H W. Cromolyn sodium: A review of mechanisms and clinical use in asthma. Drug Intell Clin Pharm 1987; 21: 22-35.
5. Bolsmann K, Braam U, Eichelberg D, Greven T, Jungbluth C, Schmutzler W, Zwadlo-Klarwasser G. Histamine release from mast cells and monocytes: The effects of azelastine, reproterol and vitamin A-analogues. Inflamm Res 1996; 45 (Suppl. 1): S5-S6.
6. Chong L K, Cooper E, Vardey C J, Peachell P T. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Br J Pharmacol 1998; 123: 1009-1015.
7. Drury D E, Chong L K, Ghahramani P, Peachell P T. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells. Br J Pharmacol 1998; 124: 711-718.
8. Botana L M, Espinosa J, Eleno N. Adrenergic activity on rat pleural and peritoneal mast cells. Loss of beta-receptors during the purification procedure. Gen Pharmacol 1987; 18: 141-148.
9. Undem B J, Graziano F M, Buckner C K. Studies on beta-adrenoceptors of purified mast cells from guinea-pig lung. Eur J Pharmacol 1985; 12: 413-416.
10. US National Institute of Health. Guide for Care and Use of Laboratory Animals. NIH Publication No. 85-23, 1988.
11. Eleno N, Botana L, Espinosa J. Valynomicin, a degranulating agent in mast cells which inhibits calcium uptake. Agents and Actions 1987; 22: 189-196.
12. Eleno N, Botana L, Espinosa J. Veratridine elicits histamine release and promotes calcium uptake in mast cells. Biochem Pharmacol 1988; 37: 3523-3525.
13. +-channel blocker 4-aminopyridine on mast cells. J Cellular Physiol 1988; 137: 378-383.
14. 45calcium-uptake in isolated mast cells. Int Arch Allergy Applied Imm 1990; 92: 162-167.
15. Shore P A. Fluorometric assay of histamine. In: Tabor H, Tabor C W, eds. Methods in Enzymology. New York: Academic Press, 1971: 842-845.
16. Shore P A. The chemical determination of histamine. In: Glick D, ed. Analysis of Biogenic Amines and Their Related Enzymes. Wiley Interscience, 1971: 89-92.
17. Hakanson R, Ronnberg A L, Sjolund K. Fluorometric determination of histamine with OPT: Optimum reaction conditions and test of identity. Anal Biochem 1972; 47: 365-370.
18. Nelson H S. β-adrenergic bronchodilators. N Engl J Med 1995; 333: 499-506.
19. 125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor. Gen Pharmacol 1987; 18: 263-267.
20. Horikoshi S, Imai T, Okamoto M, Sugeta A, Idaira K, Adachi M. Effects of SDZ ISQ 844, a cyclic nucleotide phosphodiesterase isozyme type III/IV inhibitor, on the release of histamine from human peripheral leukocytes. Arerugi 1997; 46: 426-432.
21. Nials A T, Ball D I, Butchers P R, Coleman R A, Humbles A A, Johnson M, Vardey C J. Formoterol on airway smooth muscle and human lung mast cells: A comparison with salbutamol and salmeterol. Eur J Pharmacol 1994; 251: 127-135.
22. Lau H Y, Wong P L, Lai C K. Effects of beta 2-adrenergic agonists on isolated guinea pig lung mast cells. Agents Actions 1994; 42: 92-94.
23. Page C P. Theophylline as an antiinflammatory agent. Eur Resp Rev 1996; 6: 74-78.
24. Hageman R J, de Zeeuw R A, Greving J E, Krann J J, Koeter G H. Plasma levels, heart rate, and blood pressure after intravenous, orla and aerosol administration of reproterol in man. Biopharm Drug Dispos 1988; 9: 301-314.
25. Hermann R, Ruus P, Schneider E, de Mey C. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate. Arzneimittelforschung 1998; 48: 663-667.